Scott M. Coiante - 03 Jun 2022 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
SVP, Chief Financial Officer, Director
Signature
/s/ Scott M. Coiante
Issuer symbol
APRE
Transactions as of
03 Jun 2022
Net transactions value
-$28,404
Form type
4
Filing time
07 Jun 2022, 17:02:59 UTC
Previous filing
14 Mar 2022
Next filing
01 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability $28,404 -35,284 -30% $0.8050* 84,265 03 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 86,067 restricted stock units.